Roche Diagnostics Operations, Inc. recalls
3 notices naming Roche Diagnostics Operations, Inc. as the recalling firm, since November 27, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Roche Diagnostics Operations, Inc.: cobas pro integrated solutions with cobas c 503 analytical units: cobas pro sample…
Hazard (FDA): Software defect, which allows the system to accept erroneous, non-monotonous calibrations for Spline-type assays. Cobas pro integrated solutions is an automated analyzer, intended for running qualitative…
FDAMedical devices
Roche Diagnostics Operations, Inc.: The Elecsys Anti-TSHR immunoassay is a three-step competitive immunoassay with…
Hazard (FDA): Issues identified: 1) Results vary by Instrument Platform; 2) Calibrator Lot-to-Lot Variability. Issues may lead to delayed or incorrect diagnosis, as well as delay of treatment or incorrect treatment.
FDAMedical devices
Roche Diagnostics Operations, Inc.: cobas HCYS
Hazard (FDA): Abnormal calibration signals and control recovery issues on the Homocysteine Enzymatic (HCYS) Assay can produce erroneous patient results (positive or negative bias)
FDAMedical devices